At $2 Million, New Drug For Rare Genetic Disease Set To Be Most Expensive Ever

May 15, 2019
Originally published on May 15, 2019 2:11 pm

The Food and Drug Administration is expected to approve a drug with an extremely high price tag. The new drug, called Zolgensma, treats a genetic disease called spinal muscular atrophy and is expected to cost about $2 million. WBUR’s Carey Goldberg (@goldbergcarey) reports.

This article was originally published on

Copyright 2019 NPR. To see more, visit